Our proprietary technology platform systematically leverages the powerful tools of big genomic data and AI to build molecular networks: a set of interconnected potential therapeutic targets.
Harnessing disease molecular networks, we screen both generic compounds and NCEs to develop novel drug combinations hitting multiple highly relevant disease targets.
Formulated with optimal doses of their components, our products are expected to be safer and more effective than existing therapies.
Pharnext will be hosting an Research and Development (R&D) day on Wednesday, October 27, 2021. The event will take place in New York City and will be accessed online HERE.
Pharnext will attend the AANEM 2021 Annual Meeting to be held in Aurora, Colorado (US)
Pharnext will attend the RARE 2021 Annual Meeting which is going virtual